Could exercising in thin air melt belly fat faster?
NCT ID NCT07796971
First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time
Summary
This trial tests whether high-intensity interval training (HIIT) on a stationary bike, done under low-oxygen conditions that mimic an altitude of 3,000 meters, reduces belly fat more than the same exercise in normal air. Researchers will enroll 32 adults aged 50-75 with overweight or obesity, including postmenopausal women, who will train three times a week for 12 weeks. The study measures changes in abdominal and visceral fat, along with metabolic and cardiovascular risk factors, to see if the hypoxic version offers extra benefits.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- High-intensity interval training (HIIT) on a stationary bike, performed under either low-oxygen (hypoxic) or normal-oxygen (normoxic) conditions
- What this could lead to
- If it works, this could point toward a more effective exercise program for reducing belly fat and improving metabolic health in middle-aged and older adults with overweight or obesity.
- What could go wrong
- This is a small, early-stage trial with only 32 participants, so results may not apply to everyone. The low-oxygen training may not prove more effective than standard HIIT, and some people may find the simulated altitude uncomfortable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 32 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2026
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Aged 50-75 years, inclusive Male or postmenopausal female, defined as no menstruation during the previous 12 months Body mass index between 25 and 35 kg/m², inclusive Non-smoker or smoking no more than two cigarettes per day Stable body weight for at least three months before study initiation, defined as a change of less than 4 kg Stable dietary habits and physical activity level for at least three months before study initiation Willing to maintain usual dietary habits and physical activity level throughout the study Able and willing to comply with the study protocol Able and willing to provide written informed consent Affiliated with a social security scheme Willing to be registered in the French National Register of Volunteers Participating in Biomedical Research Exclusion Criteria: Medical or surgical history considered by the investigators to be incompatible with participation in the study Any medical condition considered by the investigators to be incompatible with participation in the study Medical contraindication to vigorous physical activity Current use of hormone replacement therapy Current use of beta-blocker therapy Diagnosed moderate-to-severe sleep apnoea syndrome that is untreated or inadequately controlled High-risk cardiovascular history, including symptomatic coronary artery disease, recent myocardial infarction or stroke, unstable heart failure, clinically significant arrhythmia, or uncontrolled hypertension Severe respiratory disease, including advanced chronic obstructive pulmonary disease classified as group B or E according to the 2023 GOLD classification, chronic respiratory failure, or uncontrolled asthma Diabetes of any type Chronic kidney disease stage 3B, 4 or 5 according to the KDIGO classification Severe liver disease, defined by an international normalised ratio greater than 1.2-1.3 Antibiotic treatment during the three months preceding the first stool collection More than eight hours of moderate-to-vigorous physical activity per week Any treatment that, in the investigators' opinion, could interfere with assessment of the study outcomes Low-energy diet during the three months preceding the study or intention to begin an energy-restricted diet during the study Extreme dietary habits Stay at an altitude above 2,500 m for more than eight days during the three months preceding the study Participation in another clinical study or currently within an exclusion period following participation in a previous clinical study Total compensation received for participation in research since the beginning of the calendar year exceeding €4,500, or the applicable regulatory limit Linguistic or psychological inability to provide informed consent Refusal to provide written informed consent Legally protected adult Deprived of liberty by an administrative or judicial decision Under guardianship or curatorship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fat mass are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CREPS Auvergne Rhône-Alpes / Vichy
RECRUITINGBellerive-sur-Allier, 03321, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-World effectiveness, safety, and Patient-Reported outcomes of tirzepatide in adults with type 2 diabetes mellitus, obesity, or prediabetes in pakistan: a multicentre, prospective, observational cohort study
- Combined inspiratory muscle training and functional High-Intensity interval training promote respiratory, diaphragmatic, and aerobic adaptations in children with obesity
- Relationship between Collagen-Containing supplement use and muscle mass and body image following metabolic and bariatric surgery: a prospective observational study
- Can a dash of spice and protein shield muscle during Weight-Loss shots?
- Could a sirtuin boost make dieting more effective?
- Can a High-Protein or High-Fat Low-Carb diet tame blood sugar and triglycerides?